Methoden vergleichen

	Mixed Methods Appraisal Tool: Qualitätsbewertung über Studiendesigns hinweg	PRISMA Checklist
Fachgebiet	Forschungsmethodik	Forschungsmethodik
Familie	Process / pipeline	Process / pipeline
Entstehungsjahr	2014 (updated 2018)	2021 (original 2009)
Urheber	Pluye et al.	Page et al. (PRISMA Group)
Typ	Research methodology evaluation	Systematic review author reporting checklist
Wegweisende Quelle	Pluye, P., & Hong, Q. N. (2014). Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annual Review of Public Health, 35, 29–45.	Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.
Aliasnamen	MMAT, MMAT 2018	PRISMA, PRISMA 2020
Verwandt	4	4
Zusammenfassung	MMAT (Mixed Methods Appraisal Tool) is a practical, design-agnostic quality assessment tool developed by Pluye et al. (2014, updated 2018) to evaluate the methodological quality of quantitative (RCTs, non-randomized studies), qualitative, and mixed-methods studies. Unlike tools designed for single paradigms (e.g., Cochrane RoB 2 for RCTs), MMAT provides unified criteria applicable across diverse research methodologies, making it particularly useful for systematic reviews incorporating multiple study designs.	PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility.